Stratasys and Ricoh USA have enrolled the first patient in a clinical study to assess 3D printed models for preoperative planning in orthopaedic oncology.

The research aims to compare 3D printed anatomical models’ efficacy against the current standard of care, which involves CT or MRI imaging, to potentially improve surgical outcomes.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

As part of the study, the companies will assess if the use of these models can lead to reduced operating times, less blood loss, and a decrease in procedural complications.

The experimental group will use the 3D-printed models alongside imaging while the comparator group will rely solely on imaging for their preoperative planning.

Stratasys Medical vice-president Erez Ben Zvi said: “The collaboration brings together unparalleled experience and innovation in medical imaging and 3D printing and, if successful, may establish anatomical models as a new standard for patient treatment in tumour removal from bones.”

Scheduled for a 12-month period, the prospective, multi-centre randomised controlled study involves up to 150 subjects at three different sites.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The Ohio State University Wexner Medical Center and Corewell Health have already agreed to participate.

Ricoh USA Additive Manufacturing managing director Gary Turner said: “We are thrilled to co-sponsor this important clinical trial alongside our longstanding partners at Stratasys to further demonstrate the potential impact of 3D patient-specific modelling, as well as accelerate the adoption of this technology to better serve a broader population.”

Earlier this month, Ricoh USA unveiled its Point of Care 3D medical device manufacturing facility in the US.

Located in Winston-Salem, North Carolina, the RICOH 3D for Healthcare Innovation Studio will provide clinicians with immediate access to 3D-printed anatomic models for surgical planning and patient education.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact